Clinical trial

Cockroach Immunotherapy in Children and Adolescents

NCT03541187

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-07-16

PhasePHASE2

Study timeline

Study start (actual)2018-07-16Date precision: day

Registry last updated2023-05-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Persistent Asthmaunresolved

Interventions

German cockroach allergenic extractBIOLOGICAL

Placebo for German cockroach allergenic extractBIOLOGICAL

Sponsors & collaborators

National Institute of Allergy and Infectious Diseases (NIAID)lead sponsor

Inner-City Asthma Consortiumcollaborator

Rho Federal Systems Division, Inc.collaborator

Mapped research locations

New YorkNew York, United States2 BostonMassachusetts, United States1 ChicagoIllinois, United States1 DallasTexas, United States1 BaltimoreMaryland, United States1 St LouisMissouri, United States1 CincinnatiOhio, United States1 Washington D.C.District of Columbia, United States1 AuroraColorado, United States1 DetroitMichigan, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03541187 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.